Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Novo Nordisk is opening a new front in its fight against sickle cell disease, inking a deal with IMMvention Therapeutix to co ...

Eli Lilly (NYSE: LLY) doesn’t really need much of an introduction. It has become a household name due to its obesity and ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Partly cloudy. Slight chance of a shower. The chance of a thunderstorm. Winds south to southeasterly 25 to 35 km/h tending east to southeasterly 15 to 20 km/h in the evening. Sun protection ...